Cardiac Dimensions Sales Trigger Report

🚀 Battle Card: Cardiac Dimensions

• William T. Abraham, MD, Chief Medical Officer · 🔗 LinkedIn

• Appointment of a globally recognized heart failure expert will turbocharge regulatory submissions and commercial rollout for the Carillon Mitral Contour System®. → Source

• Leverage this Cardiac Dimensions sales trigger to tailor your pitch around FDA approval and European expansion.

• Navigating FDA regulatory hurdles for the pivotal EMPOWER Trial and U.S. market clearance

• Scaling commercial sales operations across Europe while preparing for U.S. launch

• Primary: Regulatory Consulting Services → Accelerate FDA submission timeline

• Expansion: Commercial Analytics & Sales Enablement Platform → Optimize European sales and streamline U.S. launch

• HQ: Kirkland, WA

• Employees: 100

• Rev: ≈ $25 M

• Website: cardiacdimensions.com

• Leverage this Cardiac Dimensions sales trigger to align your outreach with their top priorities.

🤼 Competitive Intel

• Abbott — Transcatheter Edge-to-Edge Repair (MitraClip)
• Unique edge: Largest clinical evidence base and widespread adoption
• Evaluated by CMO & Dir. Clinical for safety profile

• Edwards Lifesciences — Transcatheter Valve Repair (PASCAL)
• Unique edge: Adaptive closure mechanism for complex anatomies
• Evaluated by VP Ops for procedural efficiency

• Neovasc — Coronary Sinus Reducer
• Unique edge: Minimally invasive remodeling of the mitral apparatus
• Evaluated by Dir. R&D for alternative therapy in refractory patients

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑❑
OFFER_BRIEF   = ❑Regulatory consulting to accelerate FDA submission timelines❑
PROOF_METRIC  = ❑30% faster approvals❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = William
COMPANY     = Cardiac Dimensions
DEPT        = Clinical
SIZE        = 8
BOTTLENECK  = navigating FDA regulatory hurdles
EVENT       = CMO appointment
DETAIL      = William T. Abraham joins as CMO
PAIN        = slower regulatory submissions delaying market entry
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250903095354&div=41152219
SIM_CO      = V-Wave Ltd.
WIN_METRIC  = 30% faster approvals
NEXT_SIZE   = 15
EMP_EST     = 100
REV_EST     = ≈ $25M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: 8-person Clinical

William—noticed your Clinical team is ≈ 8.

That’s when navigating FDA regulatory hurdles slows growth.

We helped V-Wave Ltd. fix this with Regulatory consulting to accelerate FDA submission timelines.

Result: 30% faster approvals.  
Quick call?

PS—next bottleneck hits ≈ 15.

DM ≤45 words, TONE:
Saw your post about William T. Abraham joins as CMO — slower regulatory submissions delaying market entry.  
Regulatory consulting to accelerate FDA submission timelines. 30% faster approvals.  
Quick chat?